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Abstract
Background/aims/methods—During he-
patic vein catheterisation, in addition to
measurement of hepatic venous pressure
gradient (HVPG), iodine wedged retro-
grade portography can be easily obtained.
However, it rarely allows correct visuali-
sation of the portal vein. Recently, CO2 has
been suggested to allow better angio-
graphic demonstration of the portal vein
than iodine. In this study we investigated
the eYcacy of CO2 compared with iodi-
nated contrast medium for portal vein
imaging and its role in the evaluation of
portal hypertension in a series of 100
patients undergoing hepatic vein cath-
eterisation, 71 of whom had liver cirrho-
sis.
Results—In the overall series, CO2 venog-
raphy was markedly superior to iodine,
allowing correct visualisation of the dif-
ferent segments of the portal venous
system. In addition, CO2, but not iodine,
visualised portal-systemic collaterals in 34
patients. In cirrhosis, non-visualisation of
the portal vein on CO2 venography oc-
curred in 11 cases; four had portal vein
thrombosis and five had communications
between diVerent hepatic veins. Among
non-cirrhotics, lack of portal vein visuali-
sation had a 90% sensitivity, 88% specifi-
city, 94% negative predictive value, and
83% positive predictive value in the diag-
nosis of pre-sinusoidal portal hyper-
tension.
Conclusions—Visualisation of the venous
portal system by CO2 venography is
markedly superior to iodine. The use of
CO2 wedged portography is a useful and
safe complementary procedure during
hepatic vein catheterisation which may
help to detect portal thrombosis. Also,
lack of demonstration of the portal vein in
non-cirrhotic patients strongly suggests
the presence of pre-sinusoidal portal
hypertension.
(Gut 2000;46:856–860)
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Imaging techniques are very useful in the
assessment of the portal hypertensive patient.1
Apart from providing evidence of the presence
of portal hypertension by visualisation of
portal-systemic collaterals and/or dilated
splenic, mesenteric and portal veins, a correct
definition of the portal anatomy is essential to
rule out the presence of portal vein thrombosis,
which could be the cause of or complicate por-
tal hypertension due to chronic liver disease.2
In addition, imaging techniques are required to
evaluate pre-sinusoidal portal hypertension,
and before shunt surgery, orthotopic liver
transplantation, and hepatic resection.3 Al-
though non-invasive techniques, including du-
plex Doppler sonography, CT scan, and MR
are suYcient in many cases, direct visualisation
of the portal venous system using diVerent
angiographic techniques is frequently
required.4–8
During routine hepatic vein catheterisation,
in addition to measurement of hepatic venous
pressures, it is possible, easy, and safe to
perform retrograde wedged hepatic
venography.9–13 However, this is infrequently
done because it rarely allows correct visualisa-
tion of the portal vein. CO2 was used for imag-
ing hepatic vessels more than 30 years ago.14–18
Digital substraction techniques have greatly
improved the results of CO2 angiography,
19 and
wedged hepatic venographies using CO2 as a
radiological contrast have been used to allow
visualisation of the intrahepatic portal vein
during TIPS procedures.20
The aim of the present study was to investi-
gate the eYcacy and safety of CO2 compared
with iodinated contrast media (ICM) for visu-
alisation of the portal vein during wedged
hepatic venography. In addition, the role of
wedged hepatic venography in the evaluation of
portal hypertensive patients was assessed.
Methods
The study was performed in 100 patients (39
female and 61 male) referred for haemody-
namic evaluation of portal hypertension and/or
performance of a transjugular liver biopsy at
the Hepatic Haemodynamic Laboratory, Hos-
pital Clínic of Barcelona. All patients gave
written, informed consent before each study.
The study was approved by the ethics com-
mittee of the hospital clinic in December 1995
and was conducted in accordance with the
Helsinki Declaration of 1975, as revised in
1983.
Mean age of the patients was 55 (14) years.
Seventy one patients were known to have liver
cirrhosis based on clinical, biochemical, ultra-
sonographic, and/or histological criteria.
Thirty five belonged to Child-Pugh class A, 24
to class B, and 12 to class C. The remaining 29
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patients were non-cirrhotic and were referred
because of suspected portal hypertension
(n=16) or for a diagnostic transjugular liver
biopsy (n=13). The aetiology of cirrhosis and
diagnoses in the non-cirrhotic patients are
reported in table 1. The final diagnosis in non-
cirrhotic patients was based on liver biopsy,
mesenteric angiography, haematological, and
serological studies, which were performed as
required.
PROCEDURES
Wedged hepatic venographies using CO2 or
ICM were performed during hepatic vein cath-
eterisation. This was carried out as previously
described21 via the right femoral or jugular vein,
using a 7-F balloon occlusion catheter (Medi-
Tech, Boston Scientific Corp., Boston, Massa-
chusetts, USA). Wedged hepatic venography
was obtained after measuring wedged and free
hepatic venous pressures (WHVP and FHVP)
and the hepatic venous pressure gradient
(HVPG—diVerence between WHVP and
FHVP). Firstly, 10 ml of iodine contrast
medium (Iohexol 300 mg iodine/ml, Schering
AG, Germany) were injected as a forceful hand
injection and angiograms were recorded at
high speed (four images per second for five
seconds) using high definition fluoroscopy
(Phillips BV29, Phillips Medical Systems,
Netherlands). Afterwards, CO2 was obtained
from a high pressure unit into a 50 ml syringe
fitted with three stopcocks and two microfilters
(0.2 µm, Millex-FG, Millipore, Molsheim,
France). The syringe was rinsed with CO2,
filled to a pressure of 1 bar, and connected to
the catheter. Angiography was performed using
standard digital subtraction angiography after
opening the stopcocks, allowing rapid injection
of CO2. Dynamic images were obtained in the
same sequence used for iodine wedged hepatic
venography.
The degree of retrograde opacification of
each of the intrahepatic portal vein branches,
portal vein trunk, splenic vein, superior me-
senteric vein, and portal-systemic collaterals
was assessed in the CO2 and iodine wedge
hepatic venographs as none, slight, or marked
opacification.
DATA ANALYSIS
The dynamic portographies were evaluated
separately by two members of the team (WD,
JCB) who were blinded to the clinical data and
results of pressure measurements. Values are
shown as mean (SD). Comparisons between
groups were performed using Fisher’s exact
test or the Student’s t test, as appropriate. Sig-
nificance was established at p<0.05. All calcu-
lations were performed using the SPSS statisti-
cal package (SPSS Inc., Chicago, Illinois,
USA).
Results
In the overall series of patients, retrograde
wedged hepatic venography using CO2 as the
contrast medium was significantly better than
venography using ICM for visualisation of the
diVerent segments of the portal venous system
(table 2). CO2 venography allowed retrograde
opacification of the entire portal vein (intrahe-
patic and extrahepatic portal vein) in 71
patients (71% v 7% with iodine venography;
p<0.0001). The splenic and/or mesenteric
veins were further demonstrated with CO2
venography in 44% of patients (v 2% with
iodine venography; p<0.0001) (fig 1). Extra-
hepatic collaterals were identified with CO2 (fig
2) in 34 patients (left gastric vein n=12;
umbilical vein n=6; spontaneous splenorenal
shunt n=3; others n=13) compared with none
with iodine portography (p<0.01).
PATIENTS WITH CIRRHOSIS
In the 71 cirrhotic patients, CO2 venography
oVered significantly better results than iodine
venography, allowing visualisation of the portal
vein and/or its intrahepatic branches in 65
(85%) patients compared with 25 (35%) with
iodine venography (p<0.001). There were no
significant diVerences in age, sex, aetiology of
cirrhosis, Child-Pugh score, HVPG, or WHVP
between patients with or without opacification
of the portal vein on CO2 venography.
















Congenital hepatic fibrosis* 1
Idiopathic portal hypertension* 6
Nodular regenerative hyperplasia* 2
Others 2
†Four patients had an associated portal vein thrombosis.
*Patients with pre-sinusoidal portal hypertension.
Table 2 Degree of retrograde opacification of the portal
venous system on CO2 and iodine wedged hepatic
venography in the overall series of patients




















None 57 99 <0.0001
GOC 34 0 <0.01
RPV, right portal vein; LPV, left portal vein; PVT, portal vein
trunk; SV, splenic vein; MV, mesenteric vein; GOC, gas-
trooesophageal collaterals.
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Of the 11 patients with cirrhosis in whom
CO2 venography did not allow visualisation of
the portal vein, four had associated portal vein
thrombosis which was confirmed by duplex
Doppler ultrasonography and mesenteric
angiography. In contrast, a patient suspected of
having a portal thrombosis on sonography had
a patent portal vein. Another five cirrhotic
patients without visualisation of the portal vein
on CO2 venography had communications
between diVerent hepatic veins that precluded
adequate wedged venography as the injected
contrast escaped through another hepatic vein.
Such veno-venous communications were un-
common among patients with cirrhosis in
whom the portal vein was clearly demonstrated
after retrograde CO2 portography (6.6% v 45%
in patients without visualisation of the portal
vein, p=0.01). The remaining two patients in
whom CO2 venography did not demonstrate
the portal vein had no particular characteris-
tics.
NON-CIRRHOTIC PATIENTS
CO2 venography showed the portal vein or its
branches in 17 of 29 non-cirrhotic patients
(59%). Ten of the 12 non-cirrhotic patients in
whom CO2 venography did not visualise the
portal vein had pre-sinusoidal portal hyper-
tension compared with only one (with a granu-
lomatous hepatitis) of 17 patients in whom the
portal vein was visualised on CO2 venography
(p<0.01). Therefore, in non-cirrhotic patients
lack of visualisation of the portal vein trunk or
its branches on CO2 venography was strongly
suggestive of pre-sinusoidal portal hyper-
tension (with 90% sensitivity, 88% specificity,
94% negative predictive value, and 83%
positive predictive value in the diagnosis) (fig
3). In contrast, ICM venography did not visu-
alise the portal vein trunk or its branches in
80% of non-cirrhotic patients; hence it is of no
clinical value in the diagnosis of pre-sinusoidal
portal hypertension.
Three patients had post-sinusoidal portal
hypertension (two Budd-Chiari syndrome; one
veno-occlusive disease). In all, CO2 venography
showed complete opacification of the portal
vein trunk.
CO2 wedged venography was well tolerated.
Although 70% of patients experienced moder-
ate abdominal pain immediately after CO2
injection, it was always transient (less than
10 seconds), disappearing with rapid dissipa-
tion of intravascular CO2. After a short learning
period, performing the CO2 wedged venogra-
phy did not add more than five minutes to the
haemodynamic procedure.
Discussion
Wedged hepatic venography has long been
used for radiological visualisation of the portal
venous system.11–13 However, despite its feasi-
bility and safety, this technique is seldom used
because the portal vein is rarely completely
visualised.11 22 This was confirmed by the
present series in which wedged hepatic venog-
raphy with ICM demonstrated the intrahepatic
portal vein in only 29% of patients and the
portal vein trunk in only 7%.
Figure 1 Iodine venography (A) allowed visualisation of the distal branches of the
intrahepatic portal vein while CO2 venography (B) allowed opacification of the whole
spleno-mesenteric-portal system.
Figure 2 CO2 venography allowed visualisation of the whole spleno-mesenteric-portal
system, including the extrahepatic collaterals.
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The use of CO2 as a contrast agent in radio-
logical studies15–18 has changed this scenario.
Although CO2 venography has been extensively
used in other areas, such as renal vascular
imaging,23 there are few reports in patients with
portal hypertension. Preliminary studies sug-
gested that CO2 wedged hepatic venography
would be superior than ICM in the evaluation
of the intrahepatic portal vein during a TIPS
procedure.20 The results of our study demon-
strate the superiority of CO2 over ICM for
wedged hepatic portography for that purpose.
In addition, our data showed that CO2 wedged
hepatic venography allowed visualisation of the
extrahepatic portal vein in more than 70% of
cases. This is relevant, as in the diagnosis and
evaluation of patients with portal hypertension
recognition of portal vein patency is extremely
important. The presence of portal thrombosis
makes liver transplantation or derivative
portal-systemic surgery diYcult or even impos-
sible. Although Doppler sonography is the first
choice technique for the diagnosis of portal
thrombosis, CO2 wedged hepatic venography
may help in those patients with equivocal data
on duplex Doppler examination, avoiding the
need for more invasive techniques such as
mesenteric arteriography. Indeed, in patients
with cirrhosis, non-visualisation of the portal
vein on CO2 wedged hepatic venography, in the
absence of venous-venous communications,
strongly suggested an associated portal throm-
bosis. It is important to remark that in two of
four patients with cirrhosis and portal throm-
bosis this was not detected by routine abdomi-
nal ultrasonography for screening of hepatocel-
lular carcinoma. In addition, CO2 portography
correctly showed the absence of portal throm-
bosis in one patient where this was suspected
by duplex Doppler ultrasonography.
Among non-cirrhotic patients, 11 had pre-
sinusoidal portal hypertension. Of these 11
patients, CO2 wedged venography did not
demonstrate the portal vein in 10, and in the
remaining patient only the more peripheral
branches of the intrahepatic portal vein were
slightly opacified. Thus in a non-cirrhotic
patient with signs of portal hypertension, lack
of visualisation of the portal vein on CO2
wedged hepatic venography should indicate
pre-sinusoidal portal hypertension. Portal vein
thrombosis should be ruled out initially. How-
ever, in the presence of a patent portal vein,
other causes of pre-sinusoidal portal hyper-
tension should be considered.
Hepatic vein catheterisation is being used
extensively worldwide because measurements of
HVPG provide useful prognostic information,
especially during the pharmacological treatment
of portal hypertension.24–28 At hepatic vein cath-
eterisation, performing a CO2 wedged hepatic
portography is easy, safe, and will not require a
new procedure (it takes just a few extra
minutes). In many instances CO2 venography, in
addition to demonstrating the patency of the
portal vein, will allow full radiological mapping
of the portal venous system which may be
extremely helpful in surgical candidates. Hepatic
vein catheterisation also oVers the possibility of
performing a transjugular liver biopsy which has
been shown to be safe and useful for the diagno-
sis of liver diseases.29 30 Thus hepatic vein
catheterisation has the unique advantage of
allowing, in a single procedure, haemodynamic
measurements, retrograde CO2 portography,
and transjugular liver biopsy which may permit a
full diagnostic workout for portal hypertension
within a half-day hospital admission.
Addendum
Since the preparation of the manuscript we
have had the opportunity to study three
patients with portal vein thrombosis confirm-
ing the diagnostic accuracy of the CO2 wedged
venography technique in these patients.
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